Need help finding what you are looking for?
Contact Us
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2052353
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2052353
Immuno-Oncology Assays Market, By Product, By Technology, By Indication, By Application, By Geography
PUBLISHED:
PAGES: 165 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Immuno-Oncology Assays Market is estimated to be valued at USD 6.19 Bn in 2026 and is expected to reach USD 13.35 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 6.19 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.60% | 2033 Value Projection: | USD 13.35 Bn |
Immuno-oncology assays help analyze the expression of biomolecules like proteins that are relevant for cancer immunotherapies. These assays aid in tumor profiling, treatment strategies, and development of immunotherapies. They help evaluate expression of immune biomarkers, which provides crucial insights into cancer-immune interactions and offers direction for targeted therapies. Advancements in fields like proteomics, genomic analysis, and multiplex technologies have enabled development of high-throughput immuno-oncology assays. Their ability to gauge pre-existing antitumor immune responses and predict treatment outcomes makes them integral tools in precision oncology.
Market Dynamics
The global immuno-oncology assays market growth is driven by factors such as growing demand for targeted cancer therapies, rising adoption of combinational immunotherapies, increasing R&D investments by pharmaceutical companies, and improving availability of companion diagnostic tests. However, the market faces restraints in terms of high costs associated with immuno-oncology assays and limited reimbursement for such tests. Meanwhile, ongoing research on biomarkers and development of affordable immuno-oncology assays present significant opportunities for market players.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global immuno-oncology assays market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this includes Charles River Laboratories, F. Hoffmann-La Roche Ltd, llumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck KGaA, Invivoscribe, Inc., QIAGEN, PerkinElmer Inc., Sartorius AG, Bio-Rad Laboratories, Inc., Bruker Spatial Biology, Inc., Nexelis, Reaction Biology, Crown Bioscience, HTG Molecular Diagnostics, Inc., Axion BioSystems, Inc, and BioTherapeutics LLC
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global immuno-oncology assays market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immuno-oncology assays market
Market Segmentation
- Product Insights (Revenue, USD Bn, 2021 - 2033)
- Consumables
- Software
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Immunoassay
- PCR
- NGS
- Flow Cytometry
- Others
- Indication Insights (Revenue, USD Bn, 2021 - 2033)
- Colorectal Cancer
- Lung Cancer
- Melanoma
- Bladder Cancer
- Others
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Clinical Diagnostics
- Research and Development
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Charles River Laboratories
- F. Hoffmann-La Roche Ltd
- llumina, Inc.
- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Invivoscribe, Inc.
- QIAGEN
- PerkinElmer Inc.
- Sartorius AG
- Bio-Rad Laboratories, Inc.
- Bruker Spatial Biology, Inc.
- Nexelis
- Reaction Biology
- Crown Bioscience
- HTG Molecular Diagnostics, Inc.
- Axion BioSystems, Inc
- BioTherapeutics LLC
Product Code: CMI2632
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Technology
- Market Snapshot, By Indication
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Immuno-Oncology Assays Market, By Product, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Consumables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Software
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Immuno-Oncology Assays Market, By Technology, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Immunoassay
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- PCR
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- NGS
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Flow Cytometry
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Immuno-Oncology Assays Market, By Indication, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Colorectal Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Lung Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Melanoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Bladder Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Immuno-Oncology Assays Market, By Application, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Clinical Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Research and Development
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Immuno-Oncology Assays Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- llumina, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Invivoscribe, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sartorius AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bruker Spatial Biology, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nexelis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Reaction Biology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Crown Bioscience
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- HTG Molecular Diagnostics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Axion BioSystems, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BioTherapeutics LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Charles River Laboratories
10. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.